Nadia Tarhini: Evaluating the Risk of Recurrent Thrombosis in Children with ALL
Nadia Tarhini, Clinical Research Assistant at Boston Children’s Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Thrombosis Research, adding:
“I’m excited to announce my first co-authorship on a research publication!
I’m incredibly grateful for the opportunity to contribute to this project and gain a more in-depth knowledge about venous thrombo-embolisms among pediatric patients with acute lymphoblastic leukemia.
A special thank you to Dr. Riten Kumar on the opportunity to work collaboratively on this project and Dr. Olivia Perrone and Dr. Lynda Vrooman for their ongoing support and guidance throughout BCH/DFCI’s contribution on this project!”
Riten Kumar, Director of Thrombosis and Anticoagulation at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, reposted Nadia Tarhini’s post on LinkedIn:
“Was great to collaborate with Dr Pelland-Marcotte on this multicenter study evaluating the risk of recurrent thrombosis in children with ALL.
Notably, the risk of recurrence remains substantial, with most patients experiencing recurrent thrombosis early during treatment.
These findings underscore the need for better predictors of thrombus progression and recurrence in children with cancer associated thrombosis.”
Title: Clinical outcomes following catheter-related venous thrombo-embolism among children with acute lymphoblastic leukemia
Authors: Marie-Claude Pelland-Marcotte, Thai Hoa Tran, Chantal Éthier, Camille Beaulieu, Thien Vu Truong, Olivia Perrone, Nadia Tarhini, Juliann Duzan, Lynda M. Vrooman, Melissa Burns, Lewis B. Silverman, Riten Kumar

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization